PDGFB hypomethylation is a favourable prognostic biomarker in primary myelofibrosis.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis

• Publication date

  2015-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.leukres.2014.11.012PMID 25498506
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Somatic mutations of calreticulin in myeloproliferative neoplasms.

  2013cited by this paper
• Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2.

  2013cited by this paper
• Methylome profiling reveals distinct alterations in phenotypic and mutational subgroups of myeloproliferative neoplasms.

  2013cited by this paper
• Hypomethylation of long interspersed nuclear element-1 (LINE-1) leads to activation of proto-oncogenes in human colorectal cancer metastasis

  2013cited by this paper
• High levels of vascular endothelial growth factor protein expression are associated with an increased risk of transfusion dependence in myelodysplastic syndromes.

  2013cited by this paper
• Mutations and prognosis in primary myelofibrosis

  2013cited by this paper
• Pyrosequencing of IDH1 and IDH2 Mutations in Brain Tumors and Non-neoplastic Conditions

  2012cited by this paper
• Significance of clustered tumor suppressor genes in cancer.

  2012cited by this paper
• Myeloproliferative neoplasms 2012: the John M. Bennett 80th birthday anniversary lecture.

  2012cited by this paper
• The European Consensus on grading of bone marrow fibrosis allows a better prognostication of patients with primary myelofibrosis

  2012cited by this paper
• DNA methylation predicts recurrence from resected stage III proximal colon cancer

  2011cited by this paper
• Long interspersed nuclear element-1 hypomethylation in cancer: biology and clinical applications

  2011cited by this paper
• The Global DNA Methylation Surrogate LINE-1 Methylation Is Correlated with MGMT Promoter Methylation and Is a Better Prognostic Factor for Glioma

  2011cited by this paper
• Epigenetic modulation of the IGF2/H19 imprinted domain in human embryonic and extra-embryonic compartments and its possible role in fetal growth restriction

  2010cited by this paper
• Dynamic International Prognostic Scoring System (DIPSS) predicts progression to acute myeloid leukemia in primary myelofibrosis.

  2010cited by this paper
• Aberrant epigenetic landscape in cancer: how cellular identity goes awry.

  2010cited by this paper
• Emerging roles of PDGF-D signaling pathway in tumor development and progression.

  2010cited by this paper
• Epigenetic modifications and human disease

  2010cited by this paper
• Human DNA methylomes at base resolution show widespread epigenomic differences

  2009cited by this paper
• New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment.

  2008cited by this paper
• Cellular and molecular mechanisms underlying bone marrow and liver fibrosis: a review.

  2008cited by this paper
• The significance of bone marrow biopsy and JAK2V617F mutation in the differential diagnosis between the "early" prepolycythemic phase of polycythemia vera and essential thrombocythemia.

  2008cited by this paper
• Misbehaviour of XIST RNA in Breast Cancer Cells

  2008cited by this paper
• Prognostic implications of the European consensus for grading of bone marrow fibrosis in chronic idiopathic myelofibrosis.

  2008cited by this paper
• Role of platelet-derived growth factors in physiology and medicine.

  2008cited by this paper
• Survivin expression in “low-risk” and “high-risk” myelodysplastic syndromes

  2007cited by this paper
• MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients.

  2006cited by this paper
• Aberrant expression of transforming growth factor β‐1 (TGFβ‐1) per se does not discriminate fibrotic from non‐fibrotic chronic myeloproliferative disorders

  2005cited by this paper
• Aberrant expression of transforming growth factor beta-1 (TGF beta-1) per se does not discriminate fibrotic from non-fibrotic chronic myeloproliferative disorders.

  2005cited by this paper
• Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders.

  2005cited by this paper
• European consensus on grading bone marrow fibrosis and assessment of cellularity.

  2005cited by this paper
• Aberrant expression of platelet-derived growth factor (PDGF) and PDGF receptor-alpha is associated with advanced bone marrow fibrosis in idiopathic myelofibrosis.

  2005cited by this paper
• The PDGF family: four gene products form five dimeric isoforms.

  2004cited by this paper
• Evolution of myelofibrosis in chronic idiopathic myelofibrosis as evidenced in sequential bone marrow biopsy specimens.

  2003cited by this paper
• Megakaryocytes from chronic myeloproliferative disorders show enhanced nuclear bFGF expression.

  2002cited by this paper
• Myelofibrosis with myeloid metaplasia.

  2000cited by this paper
• Fibroblast growth factor-2.

  2000cited by this paper
• Dual implication of fibrogenic cytokines in the pathogenesis of fibrosis and myeloproliferation in myeloid metaplasia with myelofibrosis

  1999cited by this paper
• Differential effects of the various isoforms of platelet-derived growth factor on chemotaxis of fibroblasts, monocytes, and granulocytes.

  1990cited by this paper
• Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor.

  1987cited by this paper

• A Diagnostic Impact of Serum Autotaxin Levels in Patients with Bone Marrow Fibrosis.

  2022cites this paper
• Genome-wide DNA methylation profiling is able to identify prefibrotic PMF cases at risk for progression to myelofibrosis

  2021cites this paper
• Isocitrate dehydrogenase1 mutation reduces the pericyte coverage of microvessels in astrocytic tumours

  2019cites this paper
• Identification of global mRNA expression profiles and comprehensive bioinformatic analyses of abnormally expressed genes in cholestatic liver disease.

  2019cites this paper
• Expression of IL-17 and its gene promoter methylation status are associated with the progression of chronic hepatitis B virus infection

  2019cites this paper
• Comprehensive Evaluation of TFF3 Promoter Hypomethylation and Molecular Biomarker Potential for Prostate Cancer Diagnosis and Prognosis

  2017cites this paper
• MGMT-Methylated Alleles Are Distributed Heterogeneously Within Glioma Samples Irrespective of IDH Status and Chromosome 10q Deletion

  2016cites this paper
• CD18 promoter methylation is associated with a higher risk of thrombotic complications in primary myelofibrosis

  2016cites this paper
• Inflammation as a Keystone of Bone Marrow Stroma Alterations in Primary Myelofibrosis

  2015cites this paper
• Demethylation of tumor necrosis factor-α converting enzyme promoter associated with high hepatitis B e antigen level in chronic hepatitis B.

  2015cites this paper